Germany Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 5

2 Introduction 7

• 2.1 What Is This Report About? 7
• 2.2 Nephrology and Urology Devices Market Segmentation 7
• 2.3 Definitions of Markets Covered in the Report 8

3 Nephrology and Urology Devices Market, Germany 10

• 3.1 Nephrology and Urology Devices Market, Germany, Revenue ($m), 2015-2025 10
• 3.2 Nephrology and Urology Devices Market, Germany, Revenue ($m), 2015-2025 11
• 3.3 Nephrology and Urology Devices Market, Germany, Volume (Units), 2015-2025 13
• 3.4 Nephrology and Urology Devices Market, Germany, Volume (Units), 2015-2025 14
• 3.5 Nephrology and Urology Devices Market, Germany, Company Share by Revenue ($m), 2019 16

4 Renal Dialysis Equipment Market, Germany 18

• 4.1 Renal Dialysis Equipment Market, Germany, Revenue Mix ($m), 2019 18
• 4.2 Renal Dialysis Equipment Market, Germany, Segment Contribution (%), 2019 19
• 4.3 Renal Dialysis Equipment Market, Germany, Revenue ($m), 2015-2025 20
  • 4.3.1 Dialysis Accessories Market, Germany, Revenue ($m), by Segment, 2015-2025 22
  • 4.3.2 Dialysis Machines Market, Germany, Revenue ($m), by Segment, 2015-2025 25
  • 4.3.3 Vascular Access Devices for Hemodialysis Market, Germany, Revenue ($m), by Segment, 2015-2025 27
• 4.4 Renal Dialysis Equipment Market, Germany, Volume (Units), 2015-2025 30
  • 4.4.1 Dialysis Accessories Market, Germany, Volume (Units) by Segment, 2015-2025 32
  • 4.4.2 Dialysis Machines Market, Germany, Volume (Units) by Segment, 2015-2025 35
  • 4.4.3 Vascular Access Devices for Hemodialysis Market, Germany, Volume (Units) by Segment, 2015-2025 37
• 4.5 Renal Dialysis Equipment Market, Germany, Average Price ($), 2015-2025 40
• 4.6 Renal Dialysis Equipment Market, Germany, Distribution Share by Revenue ($m), 2019 42
• 4.7 Renal Dialysis Equipment Market, Germany, Company Share by Revenue ($m), 2019 43

5 Overview of Key Companies in Germany, Nephrology and Urology Devices Market 45

• 5.1 Fresenius Medical Care AG & Co KGaA 45
  • 5.1.1 Company Overview 45
• 5.2 Nipro Corp 45
  • 5.2.1 Company Overview 45
• 5.3 Baxter International Inc 45
  • 5.3.1 Company Overview 45
• 5.4 B. Braun Melsungen AG 46
  • 5.4.1 Company Overview 46
• 5.5 Asahi Kasei Corp 46
  • 5.5.1 Company Overview 46
• 5.6 Toray Medical Co Ltd 46
  • 5.6.1 Company Overview 46
• 5.7 CR Bard Inc 47
  • 5.7.1 Company Overview 47

6 Nephrology and Urology Devices Market Pipeline Products 48

7 Financial Deals Landscape 50

• 7.1 Acquisition 50
  • 7.1.1 Lubrizol Acquires Bavaria Medizin Technologie 50
• 7.2 Debt Offerings 51
  • 7.2.1 Fresenius SE Raises USD838.6 Million in Offering 0.75% International Bonds Due 2028 51
  • 7.2.2 Fresenius Medical Care Raises USD720 Million in Private Placement of 0.250% Bonds Due 2023 52
  • 7.2.3 Fresenius Medical Care Raises USD553.7 Million in Private Placement of 1.250% Bonds Due 2029 53
  • 7.2.4 Fresenius Medical Care Raises USD664.5 Million in Private Placement of 0.625% Bonds Due 2026 54
• 7.3 Partnerships 55
  • 7.3.1 Osprey Medical to Enter into Distribution Agreement with GE Healthcare 55

8 Recent Developments 56

• 8.1 Corporate Communications 56
  • 8.1.1 Dec 19, 2019: Dr. Karl Schneider retiring from Supervisory Board of Fresenius Management SE and named honorary member - Wolfgang Kirsch to join at new year 56
  • 8.1.2 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 56
  • 8.1.3 Oct 29, 2019: Fresenius Medical Care appoints Dr. Frank Maddux to management board, makes global chief medical officer a board position 57
  • 8.1.4 Sep 30, 2019: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer 57
  • 8.1.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 59
  • 8.1.6 Aug 27, 2019: Fresenius Medical Care appoints Helen Giza as Chief Financial Officer 59
  • 8.1.7 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 60
  • 8.1.8 Jul 19, 2019: Fresenius Medical Care celebrates 40th anniversary of Schweinfurt plant, company’s largest for dialysis machines 61
  • 8.1.9 May 16, 2019: Fresenius Medical Care stays on course for growth - Annual General Meeting approves 22nd straight dividend increase 61
• 8.2 Financial Announcements 62
  • 8.2.1 Feb 20, 2020: Fresenius reports 16th consecutive record year - After significant investments in 2019, company expects healthy growth in 2020 and confirms medium-term growth targets 62
  • 8.2.2 Feb 19, 2020: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth 66
  • 8.2.3 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed 69
  • 8.2.4 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 71
  • 8.2.5 Oct 29, 2019: Fresenius Medical Care again delivers strong organic growth in the third quarter 74
  • 8.2.6 Aug 13, 2019: Ritter Pharmaceuticals appoints esteemed gastroenterologist Anthony J. Lembo, M.D. to its medical advisory board 78
  • 8.2.7 Aug 02, 2019: HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019 79
  • 8.2.8 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 80
  • 8.2.9 Jun 25, 2019: Theralase brain cancer pre-clinical research accepted for publication 82
  • 8.2.10 May 21, 2019: Bellerophon presents additional positive data from cohort 1 of ongoing Phase 2/3 study of INOpulse for treatment of Pulmonary Hypertension associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference 84
  • 8.2.11 May 10, 2019: HARTMANN starts the 2019 financial year with a 4% rise in sales 87
  • 8.2.12 May 10, 2019: HARTMANN GROUP starts the 2019 financial year with a 4% rise in sales 88
  • 8.2.13 May 08, 2019: WISE starts enrolment in cortical strip electrodes study 89
  • 8.2.14 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 90
  • 8.2.15 May 02, 2019: Fresenius makes solid start to 2019 and confirms Group guidance 91
• 8.3 Government and Public Interest 95
  • 8.3.1 Feb 22, 2020: Novel data on sphingotec's biomarkers for acute and critical care settings to be presented at AKI & CRRT 2020 95
• 8.4 Other Significant Developments 96
  • 8.4.1 Mar 05, 2020: ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50 96
  • 8.4.2 Jan 23, 2020: LB Pharmaceuticals starts dosing of schizophrenia drug 96
  • 8.4.3 Jan 23, 2020: VisiQuate announces deployment of AI-based Analytics for Fresenius Medical Care 97
  • 8.4.4 Oct 22, 2019: Donate Life America and the Fresenius Medical Care Foundation announce groundbreaking National, Universal Living Donor Kidney Registry 97
  • 8.4.5 Sep 30, 2019: Interleukin 11 identified as new therapeutic target for Idiopathic Pulmonary Fibrosis 98
  • 8.4.6 Jul 30, 2019: Fresenius raises Group sales growth guidance after good second quarter 100
  • 8.4.7 Jul 10, 2019: Fresenius Medical invests in remote monitoring firm BioIntelliSense 105
  • 8.4.8 Jul 10, 2019: Fresenius Medical Care sees U.S. plans for changes to kidney disease care as positive reinforcement of company's strategy 106
• 8.5 Product News 106
  • 8.5.1 Nov 06, 2019: Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week 106
  • 8.5.2 Nov 04, 2019: Fresenius Medical Care North America announces availability of advanced water purification systems for Hemodialysis 108
  • 8.5.3 Aug 28, 2019: Fresenius Medical Care: Recall of 4008 bloodlines (AV-Set B-R F00001124 and AV-Set SRB-R F00000257) due to blood leakages 108
• 8.6 Strategy And Business Planning 109
  • 8.6.1 Apr 01, 2020: Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S. 109
  • 8.6.2 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 109
  • 8.6.3 Aug 05, 2019: Fresenius Helios expands preventive medicine offering 110
  • 8.6.4 Jul 03, 2019: Fresenius Medical Care expands clinical research activities 110
  • 8.6.5 Apr 08, 2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion 111

9 Appendix 112

• 9.1 Research Methodology 113
  • 9.1.1 Coverage 113
  • 9.1.2 Secondary Research 113
  • 9.1.3 Primary Research 114
  • 9.1.4 Market Modeling and Forecasting 114
  • 9.1.5 Company Share Analysis 116
  • 9.1.6 Distribution Share Analysis 116
  • 9.1.7 Benchmarking 117
• 9.2 GlobalData Consulting 117
• 9.3 Contact Us 118